<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1388" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1388/" /><meta name="ncbi_pagename" content="Familial Hemiplegic Migraine - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Familial Hemiplegic Migraine - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Familial Hemiplegic Migraine" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/05/14" /><meta name="citation_author" content="Joanna C Jen" /><meta name="citation_pmid" content="20301562" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1388/" /><meta name="citation_keywords" content="Sodium channel protein type 1 subunit alpha" /><meta name="citation_keywords" content="Sodium/potassium-transporting ATPase subunit alpha-2" /><meta name="citation_keywords" content="Voltage-dependent P/Q-type calcium channel subunit alpha-1A" /><meta name="citation_keywords" content="ATP1A2" /><meta name="citation_keywords" content="CACNA1A" /><meta name="citation_keywords" content="SCN1A" /><meta name="citation_keywords" content="Familial Hemiplegic Migraine" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Familial Hemiplegic Migraine" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Joanna C Jen" /><meta name="DC.Date" content="2015/05/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1388/" /><meta name="description" content="Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including familial hemiplegic migraine) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech); FHM must include motor involvement, i.e., hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with FHM1 have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia. Cerebral infarction and death have rarely been associated with hemiplegic migraine." /><meta name="og:title" content="Familial Hemiplegic Migraine" /><meta name="og:type" content="book" /><meta name="og:description" content="Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including familial hemiplegic migraine) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech); FHM must include motor involvement, i.e., hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with FHM1 have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia. Cerebral infarction and death have rarely been associated with hemiplegic migraine." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1388/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/fhm/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1388/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8836E5E041A06100000000075602BB.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1388_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1388_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fevr/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hyperchol/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1388_"><span class="title" itemprop="name">Familial Hemiplegic Migraine</span></h1><p class="contrib-group"><span itemprop="author">Joanna C Jen</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1388_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1388_ai__"><div class="contrib half_rhythm"><span itemprop="author">Joanna C Jen</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />UCLA School of Medicine<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.alcu@nejj" class="oemail">ude.alcu@nejj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 17, 2001</span>; Last Update: <span itemprop="dateModified">May 14, 2015</span>.</p><p><em>Estimated reading time: 26 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="fhm.Summary" itemprop="description"><h2 id="_fhm_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include <i>visual disturbance</i> (most common), <i>sensory loss</i> (e.g., numbness or paresthesias of the face or an extremity), and <i>dysphasia</i> (difficulty with speech); FHM must include <i>motor involvement</i>, i.e., hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with FHM1 have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia. Cerebral infarction and death have rarely been associated with hemiplegic migraine.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnostic criteria for FHM: (1) fulfills criteria for migraine with aura; (2) aura includes some degree of hemiparesis and may be prolonged; (3) at least one <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> (i.e., parent, sib, offspring) has identical attacks. Three genes are known to be associated with FHM: <i>CACNA1A</i> (FHM1), <i>ATP1A2</i> (FHM2), and <i>SCN1A</i> (FHM3).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> A trial of acetazolamide for individuals with FHM1 or a trial of standard migraine prophylactic drugs (tricyclic antidepressants, beta blockers, calcium channel blockers) for all FHM types may be warranted for frequent attacks. Antiepileptic treatment may be necessary for seizures, which are prevalent in FHM2.</p><p><i>Agents/circumstances to avoid:</i> Vasoconstricting agents because of the risk of stroke; cerebral angiography as it may precipitate a severe attack.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>FHM is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Because the diagnosis of FHM requires at least one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a>, most individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine have an affected parent. The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown. Each child of an individual with familial hemiplegic migraine has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family has been identified.</p></div></div><div id="fhm.Diagnosis"><h2 id="_fhm_Diagnosis_">Diagnosis</h2><div id="fhm.Diagnostic_Criteria"><h3>Diagnostic Criteria</h3><p>The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine (FHM) relies on clinical diagnostic criteria. Two sets of criteria have been proposed.</p><p><b>Criteria adapted from the </b><a class="bk_pop" href="#fhm.REF.headache_classification_subcommittee_of_the_international_headache_society.2004.9"><b>Headache Classification Subcommittee of the International Headache Society [2004]</b></a><b> (</b><a href="http://ihs-classification.org/en/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>full text</b></a><b>)</b></p><p>Familial hemiplegic migraine (HM) is a category of migraine with aura (MA). Diagnostic criteria for HM are as follows:</p><ul><li class="half_rhythm"><div>Headaches fulfill criteria for MA (see Note).</div></li><li class="half_rhythm"><div>Aura includes some degree of hemiparesis and may be prolonged but fully reversible.</div></li><li class="half_rhythm"><div>HM is categorized as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> if at least one <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> (i.e., parent, sib, and/or offspring) or <a class="def" href="/books/n/gene/glossary/def-item/second-degree-relative/">second-degree relative</a> has identical attacks.</div></li><li class="half_rhythm"><div>HM is <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> if no first- or <a class="def" href="/books/n/gene/glossary/def-item/second-degree-relative/">second-degree relative</a> meets criteria for hemiplegic migraine.</div></li></ul><p>Note: Migraine with aura (MA) is an <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>, recurring disorder of neurologic symptoms unequivocally localizable to the cerebral cortex or brain stem. The aura usually develops over a period of five to 20 minutes and lasts less than 60 minutes. Headache, nausea and/or photophobia usually follow neurologic aura symptoms, either immediately or after a symptom-free interval of less than an hour. The headache usually lasts four to 72 hours but may be completely absent (acephalagia). Diagnostic criteria for MA:</p><ul><li class="half_rhythm"><div>At least two episodes characterized by three or more of the following:</div><ul><li class="half_rhythm"><div>One or more aura symptoms are fully reversible, indicating focal cerebral cortical and/or brain stem dysfunction.</div></li><li class="half_rhythm"><div>At least one aura symptom develops gradually over more than four minutes, or two or more symptoms occur in succession.</div></li><li class="half_rhythm"><div>No aura symptom lasts more than 60 minutes. If more than one aura symptom is present, duration of symptoms is proportionally increased.</div></li><li class="half_rhythm"><div>Headache follows aura with a symptom-free interval of less than 60 minutes (headache may also begin before or simultaneously with the aura).</div></li></ul></li><li class="half_rhythm"><div>Ruling out of other classes of headache (i.e., head trauma, vascular disorders, nonvascular intracranial disorders, substance use or their withdrawal, non-cephalic infection, metabolic disorder, pain associated with other facial or cranial disorders)</div></li></ul><p><b>Criteria proposed by </b><a class="bk_pop" href="#fhm.REF.thomsen.2002.1379"><b>Thomsen et al [2002]</b></a><b>*</b></p><p>At least two attacks that meet all of the following criteria:</p><ul><li class="half_rhythm"><div>Fully reversible symptoms including motor weakness and at least one of the following: visual, sensory, or speech disturbance</div></li><li class="half_rhythm"><div>At least two of the following:</div><ul><li class="half_rhythm"><div>At least one aura symptom develops gradually over at least five minutes, or symptoms occur in succession.</div></li><li class="half_rhythm"><div>Each aura symptom lasts less than 24 hours.</div></li><li class="half_rhythm"><div>Some degree of headache is associated with the aura.</div></li></ul></li><li class="half_rhythm"><div>Not attributed to another disorder</div></li><li class="half_rhythm"><div>At least one first- or <a class="def" href="/books/n/gene/glossary/def-item/second-degree-relative/">second-degree relative</a> with migraine with aura including motor weakness and fulfilling all of the criteria above</div></li></ul><p>*Based on findings in 147 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from 44 families</p></div><div id="fhm.Establishing_the_Genetic_Cause"><h3>Establishing the Genetic Cause</h3><p>The genetic basis of FHM is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who meets diagnostic criteria when a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in one of the three genes known to be associated with FHM (<i>CACNA1A</i>, <i>ATP1A2,</i> and <i>SCN1A</i>) (see <a class="figpopup" href="/books/NBK1388/table/fhm.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figfhmTmoleculargenetictestingusedin" rid-ob="figobfhmTmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: (1) In the majority of persons with adult-onset hemiplegic migraine without nystagmus, seizures, or other unusual associated neurologic features, the yield for genetic testing is low. (2) Multiple studies have shown that pathogenic variants in the three known FHM-related genes are not a major cause of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> hemiplegic migraine (i.e., hemiplegic migraine in a single person in a family).</p><p><b>One genetic testing strategy</b> is serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> based on the individual&#x02019;s clinical findings (see <a href="#fhm.Clinical_Characteristics">Clinical Characteristics</a>) and/or the order in which pathogenic variants most commonly occur (i.e., <i>CACNA1A, ATP1A2, and SCN1A</i>). Note that those with pathogenic variants in <i>CACNA1A</i> commonly present with nystagmus and other cerebellar signs [<a class="bk_pop" href="#fhm.REF.ophoff.1996.543">Ophoff et al 1996</a>], and those with pathogenic variants in <i>ATP1A2</i> frequently have epilepsy [<a class="bk_pop" href="#fhm.REF.de_fusco.2003.192">De Fusco et al 2003</a>].</p><p><b>An alternative genetic testing strategy</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>CACNA1A, ATP1A2, and SCN1A</i> and other genes of interest (see <a href="#fhm.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="fhm.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Familial Hemiplegic Migraine</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1388/table/fhm.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fhm.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup><br />(Locus Name)</th><th id="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of FHM Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th></tr></thead><tbody><tr><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CACNA1A</i> (FHM1)</td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">3/42 (7%)&#x000a0;<sup>2</sup></td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP1A2</i> (FHM2)</td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/42 (7%)&#x000a0;<sup>2</sup></td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN1A</i> (FHM3)</td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4,&#x000a0;7</sup></td></tr><tr><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_fhm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fhm.TF.1.1"><p class="no_margin">See <a href="/books/NBK1388/#fhm.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#fhm.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="fhm.TF.1.2"><p class="no_margin"><a class="bk_pop" href="#fhm.REF.thomsen.2007.346">Thomsen et al [2007]</a></p></div></dd><dt>3. </dt><dd><div id="fhm.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="fhm.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used can include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="fhm.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#fhm.REF.dichgans.2005a.371">Dichgans et al [2005a]</a></p></div></dd><dt>5. </dt><dd><div id="fhm.TF.1.6"><p class="no_margin">A 39.5-kb <i>CACNA1A</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the last 16 coding exons was reported in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members of one family with episodic ataxia [<a class="bk_pop" href="#fhm.REF.riant.2008.817">Riant et al 2008</a>].</p></div></dd><dt>7. </dt><dd><div id="fhm.TF.1.7"><p class="no_margin">To date, no <i>SCN1A</i> deletions or duplications as causative of FHM have been reported.</p></div></dd><dt>8. </dt><dd><div id="fhm.TF.1.8"><p class="no_margin">Possible <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity: <a class="bk_pop" href="#fhm.REF.gardner.1997.1231">Gardner et al [1997]</a> identified an FHM susceptibility locus on 1q31, designated FHM4/MGR6, which is telomeric to FHM2 (OMIM <a href="http://omim.org/entry/607516" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607516</a>). <a class="bk_pop" href="#fhm.REF.cuencale_n.2009.191">Cuenca-Le&#x000f3;n et al [2009]</a> mapped an FHM locus to 14q32 in a large Spanish kindred.</p></div></dd></dl></div></div></div></div></div><div id="fhm.Clinical_Characteristics"><h2 id="_fhm_Clinical_Characteristics_">Clinical Characteristics</h2><div id="fhm.Clinical_Description"><h3>Clinical Description</h3><p>In migraine with aura, including <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine, the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include <b>visual disturbance</b> (most common), <b>sensory loss</b> (e.g., numbness or paresthesias of the face or an extremity), and <b>dysphasia</b> (difficulty with speech), and for FHM must include <b>motor involvement</b> (e.g., hemiparesis [weakness of an extremity]) [<a class="bk_pop" href="#fhm.REF.thomsen.2002.1379">Thomsen et al 2002</a>]:</p><ul><li class="half_rhythm"><div class="half_rhythm">Visual disturbances can include scotoma (blind spots), photopsia (flashing lights), fortification spectra (zigzag pattern), and diplopia (double vision).</div></li><li class="half_rhythm"><div class="half_rhythm">Dysphasia usually occurs when hemiplegia is right-sided.</div></li><li class="half_rhythm"><div class="half_rhythm">Hemiparesis occurs with at least one other symptom during FHM aura [<a class="bk_pop" href="#fhm.REF.ducros.2000">Ducros et al 2000</a>].</div><div class="half_rhythm">Note: Recent family studies found that approximately 10% of family members with a <i>CACNA1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> do not have hemiplegic attacks but often have migraine with or without aura [<a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al 2001</a>].</div></li></ul><p>Some confusion and/or drowsiness may be present even without dysphasia. Impaired consciousness ranging from drowsiness to coma is well described in FHM [<a class="bk_pop" href="#fhm.REF.terwindt.1998.1105">Terwindt et al 1998</a>, <a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>, <a class="bk_pop" href="#fhm.REF.vahedi.2000.1040">Vahedi et al 2000</a>]. Intermittent confusion and psychosis have been reported [<a class="bk_pop" href="#fhm.REF.feely.1982.369">Feely et al 1982</a>] including one probable family with FHM1 and ataxia [<a class="bk_pop" href="#fhm.REF.spranger.1999.150">Spranger et al 1999</a>].</p><p>Neurologic deficits with HM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. Persistent attention and memory loss can last weeks to months [<a class="bk_pop" href="#fhm.REF.kors.2003.684">Kors et al 2003</a>]. Permanent motor, sensory, language, or visual symptoms are extremely rare [<a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al 2001</a>].</p><p>Cerebral infarction and death have rarely been associated with hemiplegic migraine and should instead raise the possibility of other disorders associated with migraine and stroke (see <a href="#fhm.Differential_Diagnosis">Differential Diagnosis</a>).</p><p>Familial hemiplegic migraine is often earlier in onset than typical migraine, frequently beginning in the first or second decade. In the report of <a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al [2001]</a>, the attacks started at a young age in the majority of subjects (mean: 11.7 &#x000b1;8 years; range: 1-51 years). The natural history was variable. The frequency of attacks ranged from one per day to fewer than five in a lifetime (mean: 2-3/year). Long attack-free intervals were often reported (range: 2-37 years). The frequency of FHM attacks tends to decrease with age. The eventual neurologic outcome is often benign in the pure FHM group, although FHM1 can have progressive cerebellar deficit.</p><p>FHM attacks may be provoked by typical migraine triggers (e.g., foods, odors, exertion, stress), minor head trauma, and cerebral angiography.</p><p>Among families with hemiplegic migraine, the major significant clinical differences are presence or absence of cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia, which occurs in up to 40%-50% of families with FHM1 [<a class="bk_pop" href="#fhm.REF.ducros.2000">Ducros et al 2000</a>]; within such families, up to 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have permanent cerebellar signs [<a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al 2001</a>].</p><p>Seizures during severe attacks have been reported in some families with FHM2 along with recurrent coma in one individual [<a class="bk_pop" href="#fhm.REF.echenne.1999.214">Echenne et al 1999</a>]. Focal seizures during severe attacks have been described in two individuals with FHM1 who have no family history of FHM1 [<a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>], including one with severe intellectual disability, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> ataxia, and early cerebellar atrophy [<a class="bk_pop" href="#fhm.REF.vahedi.2000.1040">Vahedi et al 2000</a>].</p><p><b>Imaging studies.</b> The only abnormalities observed on traditional imaging studies are vermian cerebellar atrophy in some families with FHM1 [<a class="bk_pop" href="#fhm.REF.battistini.1999.38">Battistini et al 1999</a>]. Rare exceptions include transient diffusion-weighted signal changes on brain MRI suggesting cytotoxic edema during severe prolonged attacks in individuals with FHM1 [<a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>, <a class="bk_pop" href="#fhm.REF.vahedi.2000.1040">Vahedi et al 2000</a>] with hemispheric cerebral atrophy usually contralateral to the hemiparesis [<a class="bk_pop" href="#fhm.REF.hayashi.1998.166">Hayashi et al 1998</a>, <a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>, <a class="bk_pop" href="#fhm.REF.vahedi.2000.1040">Vahedi et al 2000</a>].</p><p>Abnormalities in the cerebellum on magnetic resonance spectroscopy (MRS) have been reported [<a class="bk_pop" href="#fhm.REF.dichgans.2005b.608">Dichgans et al 2005b</a>].</p></div><div id="fhm.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>CACNA1A</i>.</b> Although further correlation is needed, some suggestive <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> exist based on limited data regarding <i>CACNA1A</i> pathogenic variants commonly presenting with nystagmus and other cerebellar signs [<a class="bk_pop" href="#fhm.REF.ophoff.1996.543">Ophoff et al 1996</a>, <a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al 2001</a>].</p><ul><li class="half_rhythm"><div>p.Arg192Gln and p.Val1457Leu [<a class="bk_pop" href="#fhm.REF.carrera.1999.26">Carrera et al 1999</a>] are associated with hemiplegic attacks only, whereas unconsciousness occurs commonly during attacks with the p.Val714Ala <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#fhm.REF.terwindt.1998.1105">Terwindt et al 1998</a>].</div></li><li class="half_rhythm"><div>p.Thr666Met, p.Ile1811Leu, p.Arg583Gln [<a class="bk_pop" href="#fhm.REF.alonso.2003.610">Alonso et al 2003</a>], and p.Asp715Glu [<a class="bk_pop" href="#fhm.REF.ducros.1999.89">Ducros et al 1999</a>] have been associated with hemiplegic attacks plus ataxia. In the <a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al [2001]</a> study, p.Thr666Met was associated with the highest frequency of hemiplegic migraine, severe attacks of coma, and nystagmus. During attacks, unconsciousness sometimes occurs in individuals with the p.Thr666Met and p.Ile1811Leu pathogenic variants [<a class="bk_pop" href="#fhm.REF.terwindt.1998.1105">Terwindt et al 1998</a>]. <a class="bk_pop" href="#fhm.REF.kors.2003.684">Kors et al [2003]</a> reported a family with the p.Thr666Met <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and progressive cognitive dysfunction.</div></li><li class="half_rhythm"><div>p.Arg583Gln can be associated with stupor, fever, and progressive ataxia [<a class="bk_pop" href="#fhm.REF.battistini.1999.38">Battistini et al 1999</a>, <a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al 2001</a>]. Affected individuals were thought to have fewer attacks after treatment with acetazolamide.</div></li><li class="half_rhythm"><div>p.Asp715Glu has the lowest frequency (64%) of attacks of hemiplegic migraine [<a class="bk_pop" href="#fhm.REF.ducros.2001.17">Ducros et al 2001</a>].</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variant, p.Tyr1385Cys, identified in a single individual with no known family history of FHM, has been associated with prolonged severe attacks including focal seizures, coma, fever, and CSF neutrophilic pleocytosis [<a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>, <a class="bk_pop" href="#fhm.REF.vahedi.2000.1040">Vahedi et al 2000</a>]. Cerebral hemispheric and cerebellar atrophy are seen on imaging studies [<a class="bk_pop" href="#fhm.REF.vahedi.2000.1040">Vahedi et al 2000</a>] with reversible MRI signal changes suggestive of cytotoxic edema during attacks [<a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>]. Additionally, the single individual with the p.Thr1384Cys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had otherwise unexplained severe intellectual disability, developmental delay, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early-onset ataxia.</div></li><li class="half_rhythm"><div>p.Ser218Leu has been associated with delayed cerebral edema and fatal coma after minor head trauma [<a class="bk_pop" href="#fhm.REF.kors.2001.753">Kors et al 2001</a>].</div></li></ul><p>See <a class="figpopup" href="/books/NBK1388/table/fhm.T.selected_cacna1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figfhmTselectedcacna1apathogenicvarian" rid-ob="figobfhmTselectedcacna1apathogenicvarian">Table 2</a>.</p><p><b><i>ATP1A2</i></b></p><ul><li class="half_rhythm"><div>In the first two families in which FHM2 was genetically defined, <a class="bk_pop" href="#fhm.REF.de_fusco.2003.192">De Fusco et al [2003]</a> noted the history of seizures in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Subsequent reports of FHM2 further suggest seizures as an associated clinical feature.</div></li><li class="half_rhythm"><div>A severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with seizures, coma, and elevated temperature has been reported with a p.Gly301Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ATP1A2</i> [<a class="bk_pop" href="#fhm.REF.spadaro.2004.177">Spadaro et al 2004</a>].</div></li><li class="half_rhythm"><div>A severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with seizures and intellectual disability has been reported with the pathogenic variants p.Asp718Asn and p.Pro979Leu [<a class="bk_pop" href="#fhm.REF.jurkatrott.2004.1857">Jurkat-Rott et al 2004</a>].</div></li></ul><p>See <a class="figpopup" href="/books/NBK1388/table/fhm.T.selected_atp1a2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figfhmTselectedatp1a2pathogenicvariant" rid-ob="figobfhmTselectedatp1a2pathogenicvariant">Table 3</a>.</p></div><div id="fhm.Penetrance"><h3>Penetrance</h3><p>Penetrance for FHM1, 2, and 3 appears to be high and is estimated to be approximately 80% [<a class="bk_pop" href="#fhm.REF.jurkatrott.2004.1857">Jurkat-Rott et al 2004</a>, <a class="bk_pop" href="#fhm.REF.riant.2005.281">Riant et al 2005</a>].</p></div><div id="fhm.Nomenclature"><h3>Nomenclature</h3><p>Although families with FHM in which attacks are strikingly identical do exist, the term <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine is often used inconsistently to describe families in which different forms of migraine occur, as most individuals with hemiplegic attacks have these attacks intermingled with more frequent attacks of migraine without hemiparesis.</p></div><div id="fhm.Prevalence"><h3>Prevalence</h3><p>In Denmark, <a class="bk_pop" href="#fhm.REF.thomsen.2002.1379">Thomsen et al [2002]</a> found the prevalence of hemiplegic migraine to be 0.01% with a M:F sex ratio of 1:3 and equal prevalence of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> cases.</p></div></div><div id="fhm.Genetically_Related_Allelic_Disorder"><h2 id="_fhm_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b><i>CACNA1A</i>.</b> Two other phenotypes are associated with pathogenic variants in <i>CACNA1A:</i></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/ea2/">Episodic ataxia type 2</a> (EA2) involving episodes of ataxia and sometimes migrainous headache with interictal nystagmus associated with predominantly <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and multiexon deletions that disrupt the <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a>; some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sca6/">Spinocerebellar ataxia type 6</a> (SCA6) with late-onset progressive ataxia associated with expansion of a CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in the <i>CACNA1A</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> [<a class="bk_pop" href="#fhm.REF.zhuchenko.1997.62">Zhuchenko et al 1997</a>]. Of note, the CAG trinucleotide repeat expansion typical of SCA6 has not been observed in families with FHM [<a class="bk_pop" href="#fhm.REF.carrera.1999.26">Carrera et al 1999</a>, <a class="bk_pop" href="#fhm.REF.ducros.1999.89">Ducros et al 1999</a>]; however, some individuals with SCA6 may have migraine.</div></li></ul><p>Overlap has been described between the FHM1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (associated with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants) and the phenotypes of SCA6 and EA2.</p><ul><li class="half_rhythm"><div>One family with a CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansion characteristically observed in individuals with SCA6 had purely episodic ataxia and another family with a CAG repeat expansion had some members with episodic ataxia and others with progressive ataxia [<a class="bk_pop" href="#fhm.REF.jodice.1997.1973">Jodice et al 1997</a>].</div></li><li class="half_rhythm"><div>In one family with EA2, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members experienced hemiplegia; one family member had migraine during episodes of ataxia [<a class="bk_pop" href="#fhm.REF.jen.1999.274">Jen 1999</a>].</div></li><li class="half_rhythm"><div>In one large family with pathogenic variants in <i>CACNA1A</i>, some individuals had only hemiplegic migraine, some had only ataxia, and some had both [<a class="bk_pop" href="#fhm.REF.alonso.2003.610">Alonso et al 2003</a>].</div></li></ul><p><b><i>ATP1A2.</i></b> Pathogenic variants in <i>ATP1A2</i> have been associated with another rare clinical condition, alternating hemiplegia of childhood [<a class="bk_pop" href="#fhm.REF.bassi.2004.621">Bassi et al 2004</a>, <a class="bk_pop" href="#fhm.REF.swoboda.2004.884">Swoboda et al 2004</a>].</p><p><b><i>SCN1A</i>.</b>
<a href="/books/n/gene/gefs/"><i>SCN1A</i>-related seizure disorders</a> encompass a spectrum that ranges from simple febrile seizures (FS) and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome, also known as severe myoclonic epilepsy in infancy (SMEI) or polymorphic myoclonic epilepsy in infancy (PMEI), are usually associated with progressive dementia. Less commonly observed phenotypes include myoclonic-astatic epilepsy (MAE or Doose syndrome), Lennox-Gastaut syndrome (LGS), infantile spasms, and vaccine-related encephalopathy and seizures. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can vary even within the same family.</p></div><div id="fhm.Differential_Diagnosis"><h2 id="_fhm_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Migraine without aura</b> (OMIM <a href="http://omim.org/entry/157300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">157300</a>). Migraine without aura (MO or MOA) (common migraine) is an <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>, recurring headache disorder manifesting in attacks lasting four to 72 hours. Typical characteristics of the headache are unilateral location, pulsating quality, moderate or severe intensity, aggravation by routine physical activity, and association with nausea, photophobia, and phonophobia. This headache occurs without neurologic aura symptoms and specifically without hemiparesis.</p><p>Typical migraine is thought to be genetically complex and to have undefined environmental components. A clinical distinction between <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and nonfamilial cases has long been entertained, beginning with the first report of FHM by <a class="bk_pop" href="#fhm.REF.clarke.1910.1534">Clarke [1910]</a>. <a class="bk_pop" href="#fhm.REF.wieser.2003.272">Wieser et al [2003]</a> found no pathogenic variants in <i>CACNA1A</i> in individuals with common migraine. Some families having migraine without aura have shown linkage to 4q21 [<a class="bk_pop" href="#fhm.REF.bj_rnsson.2003.986">Bj&#x000f6;rnsson et al 2003</a>] and 14q21.2-q22.3 [<a class="bk_pop" href="#fhm.REF.soragna.2003.161">Soragna et al 2003</a>]. One family having migraine with or without aura showed linkage to 6p12.2-p21.1 [<a class="bk_pop" href="#fhm.REF.carlsson.2002.1804">Carlsson et al 2002</a>].</p><p><b>Migraine with aura</b> (OMIM <a href="http://omim.org/entry/157300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">157300</a>). <a class="bk_pop" href="#fhm.REF.brugnoni.2002.1">Brugnoni et al [2002]</a> found no <i>CACNA1A</i> pathogenic variants in individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> migraine with aura. Some families having migraine with aura show linkage to 4q24 [<a class="bk_pop" href="#fhm.REF.wessman.2002.652">Wessman et al 2002</a>].</p><p><b>"Sporadic" hemiplegic migraine (SHM).</b> "Sporadic" hemiplegic migraine refers to <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with no relatives with hemiplegic migraine). Such individuals may or may not have other family members with typical migraine. To investigate the genetic basis of hemiplegic migraine in simplex cases:</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#fhm.REF.terwindt.2002.1016">Terwindt et al [2002]</a> evaluated 27 individuals who had no family history of hemiplegic migraine and found a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CACNA1A</i> in two, one of whom had ataxia, nystagmus, and cerebellar atrophy on cranial CT; the other did not.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#fhm.REF.de_vries.2007.2170">de Vries et al [2007]</a> sequenced all three FHM-related genes in 39 individuals with SHM and found one <i>CACNA1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (FHM1), five <i>ATP1A2</i> pathogenic variants (FHM2), and one <i>SCN1A</i> <a class="def" href="/books/n/gene/glossary/def-item/benign-variant/">benign variant</a> (FHM3).</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#fhm.REF.thomsen.2008.914">Thomsen et al [2008]</a> examined 100 individuals with SHM and found only a handful of novel, not clearly pathogenic nucleotide variants in <i>CACNA1A</i> and <i>ATP1A2</i>, suggesting that FHM-related genes are not major genes in SHM.</div></li></ul><p>Other inherited disorders associated with migrainous headache that may include hemiplegic aura:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/melas/"><b>MELAS</b></a><b>,</b>
<a href="/books/n/gene/merrf/"><b>MERRF</b></a><b>, and other</b>
<a href="/books/n/gene/mt-overview/"><b>mitochondrial disorders</b></a><b>.</b> MELAS is a multisystem disorder with onset typically between ages two and ten years. The most common initial symptoms are generalized tonic-clonic seizures, recurrent headaches, anorexia, and recurrent vomiting. Seizures are often associated with stroke-like episodes of transient hemiparesis or cortical blindness, which may be associated with altered consciousness and may be recurrent. The cumulative residual effects of the stroke-like episodes gradually impair motor abilities, vision, and cognition, often by adolescence or young adulthood. Sensorineural hearing loss is common. The most common mitochondrial DNA (mtDNA) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, present in more than 80% of individuals with typical clinical findings of MELAS, is an A-to-G transition at nucleotide 3243 in the tRNALeu(UUR) of mtDNA.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/cadasil/"><b>CADASIL</b></a> (<i>c</i>erebral <i>a</i>utosomal <i>d</i>ominant <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy) is characterized by history of migraine with aura, mid-adult (30s-60s) onset of cerebrovascular, mood disturbance, apathy, cognitive disturbance progressing to dementia, and diffuse white matter lesions and subcortical infarcts on neuroimaging. One family with CADASIL was reported to have hemiparetic aura [<a class="bk_pop" href="#fhm.REF.hutchinson.1995.817">Hutchinson et al 1995</a>]. The pathologic hallmark of CADASIL is electron-dense granules in the media of arterioles that can often be identified by electron microscopic (EM) evaluation of skin biopsies. More than 90% of individuals have pathogenic variants in <i>NOTCH3</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><b>RVCL</b> (<i>r</i>etinal <i>v</i>asculopathy with <i>c</i>erebral <i>l</i>eukodystrophy) (OMIM <a href="http://omim.org/entry/192315" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">192315</a>) is characterized by systemic microvasculopathy with adult onset (30s-40s) of retinal vasculopathy and cerebrovascular disease variably associated with migraine. The pathologic hallmark of RVCL is multi-laminated subendothelial basement membrane by EM evaluation of multiple organs including skin. Affected individuals have pathogenic variants in <i>TREX1</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hht/"><b>Hereditary hemorrhagic telangiectasia</b></a> (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. Small AVMs, or telangiectases, close to the surface of skin and mucous membranes often rupture and bleed after slight trauma. The most common clinical manifestation is spontaneous and recurrent nosebleeds beginning at approximately age 12 years. Large AVMs often cause symptoms when they occur in brain, lung, or the gastrointestinal tract; complications from bleeding or shunting may be sudden and catastrophic. Migraine with aura has been reported in 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. HHT is caused by pathogenic variants in <i>ENG</i>, <i>ACVRL1</i>, <i>SMAD4</i>, and at least two other as-yet unidentified genes. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ccm/"><b>Familial cerebral cavernous malformations</b></a> (CCMs) are vascular malformations in the brain and spinal cord consisting of closely clustered enlarged capillary channels (caverns) with a single layer of endothelium without normal intervening brain parenchyma or mature vessel wall elements. CCMs have been reported in infants and children, but the majority of individuals present with symptoms between the second and fifth decades. Approximately 50%-75% of persons with CCM have symptoms, including seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage. Up to 50% of individuals with CCM remain symptom free throughout their lives. The three genes associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> CCM are <i>KRIT1</i>, <i>CCM2</i>, and <i>CCM3</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><b>Dutch form of</b> hereditary cerebral amyloid angiopathy (OMIM <a href="http://omim.org/entry/605714" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605714</a>). Migraines often precede the onset of cerebral and cerebellar hemorrhage in the fourth or fifth decade. Senile plaques and vascular wall amyloid are found in the brain in association with amino acid changes in the APP beta-amyloid precursor protein, a protease inhibitor. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li></ul><p><b>Alternating hemiplegia of childhood (AHC)</b> is a rare condition with clinical features that overlap with FHM. AHC is characterized by recurrent hemiplegia with onset before age 18 months, variable other transient neurological findings, and progressive cognitive decline<b>.</b> Some individuals with AHC have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ATP1A2</i> (the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that is mutated in FHM2) [<a class="bk_pop" href="#fhm.REF.bassi.2004.621">Bassi et al 2004</a>, <a class="bk_pop" href="#fhm.REF.swoboda.2004.884">Swoboda et al 2004</a>]; however, the majority are heterozygous for a pathogenic variant in <i>ATP1A3</i> [<a class="bk_pop" href="#fhm.REF.heinzen.2012.1030">Heinzen et al 2012</a>] and are allelic with rapid-onset dystonia parkinsonism and CAPOS. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Hemiplegia.</b> The differential diagnosis of hemiplegia includes post-ictal weakness following seizure, transient ischemic attack (TIA), stroke, and other non-genetic causes of transient hemiparesis.</p><p><b>Stroke.</b> When family history is positive for hemiparetic attacks with migraine, the presence of infarct on imaging studies raises the possibility of other inherited disorders such as <a href="/books/n/gene/melas/">MELAS</a>, <a href="/books/n/gene/cadasil/">CADASIL</a>, or thrombophilia, such as <a href="/books/n/gene/factor-v-leiden/">factor V Leiden</a> [<a class="bk_pop" href="#fhm.REF.gaustadnes.1999.251">Gaustadnes et al 1999</a>]. Additional stroke risk factors may also be present.</p><p>Caution: Even with normal imaging studies and description of spreading aura, an age-appropriate stroke evaluation should be considered at presentation. Overlap in clinical features, inaccuracies of historical family information, rarity of true FHM, and the seriousness of stroke-related disorders warrant this cautious approach. Stroke or other CNS-related disorders should be even more strongly considered if family history is negative for hemiplegic migraine.</p></div><div id="fhm.Management"><h2 id="_fhm_Management_">Management</h2><div id="fhm.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> or <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> hemiplegic migraine, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Quantitative eye movement examination in individuals with nystagmus or complaints of incoordination or imbalance to look for additional clues of cerebellar involvement</div></li><li class="half_rhythm"><div>EEG and neuroimaging studies if seizures are present in order to further characterize the seizure disorder.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="fhm.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Symptomatic support during an episode of hemiplegic migraine is the only therapy available.</p><p>A trial of acetazolamide for individuals with FHM1 or a trial of standard migraine prophylactic drugs (tricyclic antidepressants, beta blockers, calcium channel blockers, anti-epileptic medications) for all FHM types may be warranted for frequent attacks. Limited correlation exists between drug response and hemiplegic migraine type.</p><p>There are anecdotal reports of therapeutic response to antiepileptic medications including topiramate, lacosamide, levetiracetam, and valproate, along with other medications commonly used for migraine prophylaxis.</p><p>Antiepileptic treatment may be necessary for seizures that are prevalent in FHM2 (caused by pathogenic variants in <i>ATP1A2)</i>.</p></div><div id="fhm.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In general, vasoconstricting agents should be avoided because of the risk of stroke.</p><p>Cerebral angiography is hazardous as it may precipitate a severe attack [<a class="bk_pop" href="#fhm.REF.chabriat.2000.510">Chabriat et al 2000</a>].</p></div><div id="fhm.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#fhm.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="fhm.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="fhm.Genetic_Counseling"><h2 id="_fhm_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="fhm.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Familial hemiplegic migraine is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="fhm.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Because the diagnosis of FHM requires at least one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a>, most individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine have an affected parent.</div></li><li class="half_rhythm"><div>The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CACNA1A</i>, <i>ATP1A2</i>, or <i>SCN1A</i> is unknown but probably low.</div><ul><li class="half_rhythm"><div>Limited data for FHM have been reported [<a class="bk_pop" href="#fhm.REF.carrera.1999.26">Carrera et al 1999</a>, <a class="bk_pop" href="#fhm.REF.ducros.1999.89">Ducros et al 1999</a>].</div></li><li class="half_rhythm"><div>Twenty-three of 25 individuals with early onset hemiplegic migraine (mean age of clinical onset 7.7 +/- 3.4 years) had a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CACNA1A</i> or <i>ATP1A2</i>. Nineteen of 23 were <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> (i.e., not identified in either parent) [<a class="bk_pop" href="#fhm.REF.riant.2010.967">Riant et al 2010</a>].</div></li><li class="half_rhythm"><div><i>De novo</i> pathogenic variants in an FHM-related <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> have been reported in "<a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a>" hemiplegic migraine (see <a href="#fhm.Differential_Diagnosis">Differential Diagnosis</a>) in a small number of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., single occurrences of FHM in a family) [<a class="bk_pop" href="#fhm.REF.terwindt.2002.1016">Terwindt et al 2002</a>, <a class="bk_pop" href="#fhm.REF.de_vries.2007.2170">de Vries et al 2007</a>, <a class="bk_pop" href="#fhm.REF.thomsen.2008.914">Thomsen et al 2008</a>].</div></li></ul></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of an individual with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include clinical interview, neurologic examination, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the pathogenic variant has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="fhm.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk of being affected.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="fhm.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CACNA1A, ATP1A2, or SCN1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions reagarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="fhm.Resources"><h2 id="_fhm_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/familial-hemiplegic-migraine" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Familial hemiplegic migraine</a></div></li><li class="half_rhythm"><div><b>MAGNUM - Migraine Awareness Group: A National Understanding for Migraineurs</b></div><div>The National Migraine Association</div><div>100 North Union Street</div><div>Suite B</div><div>Alexandria VA 22314</div><div><b>Phone:</b> 703-349-1929</div><div><b>Fax:</b> 800-884-1300 (toll-free)</div><div><b>Email:</b> comments@migraines.org</div><div><a href="http://www.migraines.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.migraines.org</a></div></li><li class="half_rhythm"><div><b>National Headache Foundation</b></div><div>820 North Orleans</div><div>Suite 411</div><div>Chicago IL 60610</div><div><b>Phone:</b> 888-NHF-5552</div><div><b>Email:</b> info@headaches.org</div><div><a href="http://www.headaches.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.headaches.org</a></div></li></ul></div><div id="fhm.Molecular_Genetics"><h2 id="_fhm_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="fhm.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Familial Hemiplegic Migraine: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1388/table/fhm.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fhm.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_fhm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_fhm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_fhm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_fhm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_fhm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_fhm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_fhm.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_fhm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FHM1</td><td headers="hd_b_fhm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/773" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CACNA1A</i></a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=773" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00555" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Voltage-dependent P/Q-type calcium channel subunit alpha-1A</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/CACNA1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (CACNA1A) @ LOVD</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CACNA1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CACNA1A</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CACNA1A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CACNA1A</a></td></tr><tr><td headers="hd_b_fhm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FHM2</td><td headers="hd_b_fhm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/477" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ATP1A2</i></a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=477" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q23<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P50993" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium/potassium-transporting ATPase subunit alpha-2</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/ATP1A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide (ATP1A2) @ LOVD</a><br /><a href="https://databases.lovd.nl/shared/genes/ATP1A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Familial Hemiplegic Migraine (FHM) Variation Database (ATP1A2)</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATP1A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATP1A2</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ATP1A2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATP1A2</a></td></tr><tr><td headers="hd_b_fhm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FHM3</td><td headers="hd_b_fhm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6323" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SCN1A</i></a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6323" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P35498" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium channel protein type 1 subunit alpha</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/SCN1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN1A gene database</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SCN1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN1A</a></td><td headers="hd_b_fhm.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SCN1A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN1A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="fhm.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="fhm.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Familial Hemiplegic Migraine (<a href="/omim/141500,182340,182389,601011,602481,609634" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1388/table/fhm.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fhm.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/141500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">141500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/182340" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">182340</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/182389" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">182389</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601011" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601011</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602481" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602481</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609634" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609634</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3</td></tr></tbody></table></div></div><p><b><i>CACNA1A</i></b></p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises 47 exons spanning 300 kb. It is alternatively spliced, notably with an alternative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 37 [<a href="/entrez/viewer.fcgi?val=NM_001127221.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001127221.1</a> RefSeq transcript variant 3] and an alternative <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> for exon 47 which contains polymorphic CAG repeats, with the longer transcript rendering the CAG repeats in frame for polyglutamine. Pathogenic variants have been identified in exon 37a and exon 37b. Furthermore, CAG repeat expansions with more than 21 repeats cause SCA6 link with incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. For a detailed summary of gene and protein information, see <a href="/books/NBK1388/#fhm.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Thr666Met is the most common, with no evidence for <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#fhm.REF.ducros.1999.89">Ducros et al 1999</a>]. See <a class="figpopup" href="/books/NBK1388/table/fhm.T.selected_cacna1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figfhmTselectedcacna1apathogenicvarian" rid-ob="figobfhmTselectedcacna1apathogenicvarian">Table 2</a>.</p><div id="fhm.T.selected_cacna1a_pathogenic_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>CACNA1A</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1388/table/fhm.T.selected_cacna1a_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fhm.T.selected_cacna1a_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.575G&#x0003e;A</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg192Gln</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_3" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_001127221.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001127221<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/entrez/viewer.fcgi?val=NP_001120693.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001120693<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/nuccore/1657332" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">X99897</a>&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.653C&#x0003e;T</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser218Leu</td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1748G&#x0003e;A</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg583Gln</td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2141T&#x0003e;C</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val714Ala</td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2145C&#x0003e;G</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp715Glu</td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1997C&#x0003e;T</td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr666Met</td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4151A&#x0003e;G<br />(c.4154A&#x0003e;G)&#x000a0;<sup>2</sup></td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr1384Cys<br />(p.Tyr1385Cys)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.5428A&#x0003e;C<br />(c.5431A&#x0003e;C)&#x000a0;<sup>2</sup></td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile1810Leu<br />(p.Ile1811Leu)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4366G&#x0003e;T<br />(c.4369G&#x0003e;T)&#x000a0;<sup>2</sup></td><td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val1456Leu<br />(p.Val1457Leu)&#x000a0;<sup>2</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="fhm.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="fhm.TF.2.2"><p class="no_margin">Variant designations are given for an alternate reference sequence. X99897 is an alternate <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> commonly used in the literature. Compared to NM_001127221.1, it has an extra three nucleotides (AAG) at nucleotide 3623_3625, resulting in an additional Glu residue.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene encodes the alpha-1 subunit of a neural voltage-dependent P/Q-type calcium channel important in synaptic transmission in the central nervous system as well as at the neuromuscular junction. The alpha-1 subunit forms the voltage sensor and pore of the calcium channel.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants affect the pore or the voltage sensor parts of the ion channel. <a class="bk_pop" href="#fhm.REF.tottene.2002.13284">Tottene et al [2002]</a> found that mutational changes of functional channel densities can be different in different cell types, and identified two functional effects common to all FHM-causing pathogenic variants analyzed: increase of single-channel Ca<sup>2+</sup> influx and decrease of maximal Ca(V)2.1 current density in neurons.</p><p>Subsequent studies in FHM1 knockin mouse models further demonstrated enhanced excitatory (but not inhibitory) synaptic neurotransmission as the basis for facilitated spreading depression thought to underlie migraine in humans [<a class="bk_pop" href="#fhm.REF.tottene.2009.762">Tottene et al 2009</a>, <a class="bk_pop" href="#fhm.REF.di_guilmi.2014.7047">Di Guilmi et al 2014</a>, <a class="bk_pop" href="#fhm.REF.vecchia.2014.225">Vecchia et al 2014</a>, <a class="bk_pop" href="#fhm.REF.vecchia.2015.8">Vecchia et al 2015</a>].</p><p><b><i>ATP1A2</i></b></p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has 23 exons spanning 25 kb. For a detailed summary of gene and protein information, see <a href="/books/NBK1388/#fhm.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Since the first report of p.Leu764Pro and p.Trp887Arg [<a class="bk_pop" href="#fhm.REF.de_fusco.2003.192">De Fusco et al 2003</a>], more than 80 pathogenic variants in <i>ATP1A2</i> have been described in FHM2 or <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> hemiplegic migraine.</p><p>The great majority are pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, with a handful of frameshift pathogenic variants [<a class="bk_pop" href="#fhm.REF.riant.2005.281">Riant et al 2005</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant with premature termination p.Tyr1009Ter was identified in a child with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> hemiplegic migraine and epilepsy [<a class="bk_pop" href="#fhm.REF.gallanti.2008.123">Gallanti et al 2008</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> was predicted to lead to p.Ter1021Arg (*1021R), with alteration of the termination code to add 28 novel amino acid residues to the C terminus [<a class="bk_pop" href="#fhm.REF.jurkatrott.2004.1857">Jurkat-Rott et al 2004</a>]. See <a class="figpopup" href="/books/NBK1388/table/fhm.T.selected_atp1a2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figfhmTselectedatp1a2pathogenicvariant" rid-ob="figobfhmTselectedatp1a2pathogenicvariant">Table 3</a>.</p><div id="fhm.T.selected_atp1a2_pathogenic_variant" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>ATP1A2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1388/table/fhm.T.selected_atp1a2_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fhm.T.selected_atp1a2_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.901G&#x0003e;A</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly301Arg</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000702.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000702<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?val=NP_000693.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000693<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2066G&#x0003e;A</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg689Gln</td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2152G&#x0003e;A</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp718Asn</td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2192T&#x0003e;C</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met731Thr</td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2291T&#x0003e;C</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu764Pro</td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2659T&#x0003e;C</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp887Arg</td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2936C&#x0003e;T</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro979Leu</td></tr><tr><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3061T&#x0003e;C</td><td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ter1021Argext28<br />(also known as p.X1021Arg)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="fhm.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> A heterodimeric protein, expressed largely in astrocytes, has ten transmembrane domains with a large catalytic &#x003b1;-subunit and a smaller ancillary &#x003b2;-subunit. The pump hydrolyzes ATP to exchange intracellular Na+ for extracellular K+ to maintain not only the resting potential but also the electrochemical gradient that drives transporters.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The two pathogenic variants found by <a class="bk_pop" href="#fhm.REF.de_fusco.2003.192">De Fusco et al [2003]</a>, p.Leu764Pro and p.Trp887Arg, cause loss of function of the &#x003b1;2-subunit leading to <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>, which appears to be the general rule for FHM2-causing pathogenic variants. Expression studies of mostly <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and p.Ter1021Argext28 revealed important functional domains for protein conformation, plasma membrane targeting, turnover, cation affinity, and voltage dependence [<a class="bk_pop" href="#fhm.REF.tavraz.2008.31097">Tavraz et al 2008</a>]. The p.Ter1021Argext28 <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> changes the stop codon (*) to Arg and extends the protein by a total of 28 amino acids.</p><p><b><i>SCN1A</i></b></p><p><b>Gene structure.</b>
<i>SCN1A</i> comprises 26 exons spanning 82 kb.</p><p><b>Pathogenic variants</b> associated with FHM include p.Leu263Val [<a class="bk_pop" href="#fhm.REF.castro.2009.308">Castro et al 2009</a>], p.Thr1174Ser [<a class="bk_pop" href="#fhm.REF.gargus.2007.407">Gargus &#x00026; Tournay 2007</a>], p.Gln1489Lys [<a class="bk_pop" href="#fhm.REF.dichgans.2005a.371">Dichgans et al 2005a</a>], p.Leu1649Gln [<a class="bk_pop" href="#fhm.REF.vanmolkot.2007.522">Vanmolkot et al 2007</a>], and p.Phe1499Leu and p.Gln1489His [<a class="bk_pop" href="#fhm.REF.vahedi.2009.1178">Vahedi et al 2009</a>]. See <a class="figpopup" href="/books/NBK1388/table/fhm.T.selected_scn1a_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfhmTselectedscn1apathogenicvariants" rid-ob="figobfhmTselectedscn1apathogenicvariants">Table 4</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1388/#fhm.molgen.TA">Table A</a>, <b>Gene</b>.</p><div id="fhm.T.selected_scn1a_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>SCN1A</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1388/table/fhm.T.selected_scn1a_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fhm.T.selected_scn1a_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.787C&#x0003e;G</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu263Val</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=AB093548.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AB093548<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3521C&#x0003e;G</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr1174Ser</td></tr><tr><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4465C&#x0003e;A</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln1489Lys</td></tr><tr><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4467G&#x0003e;C</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln1489His</td></tr><tr><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4495T&#x0003e;C</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe1499Leu</td></tr><tr><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4946T&#x0003e;A</td><td headers="hd_h_fhm.T.selected_scn1a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu1649Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene encodes the voltage-sensing and ion-conducting &#x003b1;1-subunit of a neural voltage-dependent sodium channel.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenic variants p.Gln1489Lys and p.Leu1649Gln associated with pure hemiplegic migraine showed loss of channel function, while p.Leu263Val associated with both hemiplegic migraine and epilepsy exhibited gain of channel function [<a class="bk_pop" href="#fhm.REF.kahlig.2008.9799">Kahlig et al 2008</a>].</p></div><div id="fhm.References"><h2 id="_fhm_References_">References</h2><div id="fhm.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.alonso.2003.610">Alonso I, Barros J, Tuna A, Coelho J, Sequeiros J, Silveira I, Coutinho P. Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:610–4.</span> [<a href="/pubmed/12707077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.bassi.2004.621">Bassi MT, Bresolin N, Tonelli A, Nazos K, Crippa F, Baschirotto C, Zucca C, Bersano A, Dolcetta D, Boneschi FM, Barone V, Casari G. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:621–8.</span> [<a href="/pmc/articles/PMC1735877/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735877</span></a>] [<a href="/pubmed/15286158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15286158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.battistini.1999.38">Battistini S, Stenirri S, Piatti M, Gelfi C, Righetti PG, Rocchi R, Giannini F, Battistini N, Guazzi GC, Ferrari M, Carrera P. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:38–43.</span> [<a href="/pubmed/10408534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10408534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.bj_rnsson.2003.986">Bj&#x000f6;rnsson A, Gudmundsson G, Gudfinnsson E, Hrafnsdottir M, Benedikz J, Skuladottir S, Kristjansson K, Frigge ML, Kong A, Stefansson K, Gulcher JR. Localization of a Gene for Migraine without Aura to Chromosome 4q21. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">73</span>:986–93.</span> [<a href="/pmc/articles/PMC1180504/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180504</span></a>] [<a href="/pubmed/14513409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14513409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.brugnoni.2002.1">Brugnoni R, Leone M, Rigamonti A, Moranduzzo E, Cornelio F, Mantegazza R, Bussone G. Is the CACNA1A gene involved in familial migraine with aura? <span><span class="ref-journal">Neurol Sci. </span>2002;<span class="ref-vol">23</span>:1–5.</span> [<a href="/pubmed/12111613" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12111613</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.carlsson.2002.1804">Carlsson A, Forsgren L, Nylander PO, Hellman U, Forsman-Semb K, Holmgren G, Holmberg D, Holmberg M. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1804–7.</span> [<a href="/pubmed/12473779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12473779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.carrera.1999.26">Carrera P, Piatti M, Stenirri S, Grimaldi LM, Marchioni E, Curcio M, Righetti PG, Ferrari M, Gelfi C. Genetic heterogeneity in Italian families with familial hemiplegic migraine. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:26–33.</span> [<a href="/pubmed/10408532" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10408532</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.castro.2009.308">Castro MJ, Stam AH, Lemos C, de Vries B, Vanmolkot KR, Barros J, Terwindt GM, Frants RR, Sequeiros J, Ferrari MD, Pereira-Monteiro JM, van den Maagdenberg AM. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. <span><span class="ref-journal">Cephalalgia. </span>2009;<span class="ref-vol">29</span>:308–13.</span> [<a href="/pubmed/19220312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19220312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.chabriat.2000.510">Chabriat H, Vahedi K, Clark CA, Poupon C, Ducros A, Denier C, Le Bihan D, Bousser MG. Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:510–2.</span> [<a href="/pubmed/10668728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10668728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.clarke.1910.1534">Clarke JM. On recurrent motor paralysis in migraine. <span><span class="ref-journal">Br Med J. </span>1910;<span class="ref-vol">1</span>:1534–8.</span> [<a href="/pmc/articles/PMC2331895/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2331895</span></a>] [<a href="/pubmed/20765161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20765161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.cuencale_n.2009.191">Cuenca-Le&#x000f3;n E, Corominas R, Montfort M, Artigas J, Roig M, Bay&#x000e9;s M, Cormand B, Macaya A. Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred. <span><span class="ref-journal">Neurogenetics. </span>2009;<span class="ref-vol">10</span>:191–8.</span> [<a href="/pubmed/19153782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19153782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.de_fusco.2003.192">De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:192–6.</span> [<a href="/pubmed/12539047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12539047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.de_vries.2007.2170">de Vries B, Freilinger T, Vanmolkot KR, Koenderink JB, Stam AH, Terwindt GM, Babini E, van den Boogerd EH, van den Heuvel JJ, Frants RR, Haan J, Pusch M, van den Maagdenberg AM, Ferrari MD, Dichgans M. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:2170–6.</span> [<a href="/pubmed/18056581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18056581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.di_guilmi.2014.7047">Di Guilmi MN, Wang T, Inchauspe CG, Forsythe ID, Ferrari MD, van den Maagdenberg AM, Borst JG, Uchitel OD. Synaptic gain-of-function effects of mutant Cav2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca2+]i. <span><span class="ref-journal">J Neurosci. </span>2014;<span class="ref-vol">34</span>:7047–58.</span> [<a href="/pmc/articles/PMC4028489/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4028489</span></a>] [<a href="/pubmed/24849341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24849341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.dichgans.2005a.371">Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. <span><span class="ref-journal">Lancet. </span>2005a;<span class="ref-vol">366</span>:371–7.</span> [<a href="/pubmed/16054936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16054936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.dichgans.2005b.608">Dichgans M, Herzog J, Freilinger T, Wilke M, Auer DP. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. <span><span class="ref-journal">Neurology. </span>2005b;<span class="ref-vol">64</span>:608–13.</span> [<a href="/pubmed/15728280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15728280</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.ducros.2001.17">Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. <span><span class="ref-journal">N Engl J Med. </span>2001;<span class="ref-vol">345</span>:17–24.</span> [<a href="/pubmed/11439943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11439943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.ducros.1999.89">Ducros A, Denier C, Joutel A, Vahedi K, Michel A, Darcel F, Madigand M, Guerouaou D, Tison F, Julien J, Hirsch E, Chedru F, Bisgard C, Lucotte G, Despres P, Billard C, Barthez MA, Ponsot G, Bousser MG, Tournier-Lasserve E. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:89–98.</span> [<a href="/pmc/articles/PMC1377706/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377706</span></a>] [<a href="/pubmed/9915947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9915947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.ducros.2000">Ducros A, Joutel A, Vahedi K, Bousser MG, Tournier-Lasserve E. Genotype-phenotype correlations in familial hemiplegic migraine. In: Olesen J, Bousser MG, eds. <em>Frontiers in Headache Research: Genetics of Headache Disorders</em>. Vol 8. Philadelphia, PA: Lippincott, Williams, &#x00026; Wilkins; 2000:123-7.</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.echenne.1999.214">Echenne B, Ducros A, Rivier F, Joutel A, Humbertclaude V, Roubertie A, Azais M, Bousser MG, Tournier-Lasserve E. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. <span><span class="ref-journal">Neuropediatrics. </span>1999;<span class="ref-vol">30</span>:214–7.</span> [<a href="/pubmed/10569214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10569214</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.feely.1982.369">Feely MP, O'Hare J, Veale D, Callaghan N. Episodes of acute confusion or psychosis in familial hemiplegic migraine. <span><span class="ref-journal">Acta Neurol Scand. </span>1982;<span class="ref-vol">65</span>:369–75.</span> [<a href="/pubmed/7102264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7102264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.gallanti.2008.123">Gallanti A, Tonelli A, Cardin V, Bussone G, Bresolin N, Bassi MT. A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures. <span><span class="ref-journal">J Neurol Sci. </span>2008;<span class="ref-vol">273</span>:123–6.</span> [<a href="/pubmed/18644608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18644608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.gardner.1997.1231">Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:1231–8.</span> [<a href="/pubmed/9371899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9371899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.gargus.2007.407">Gargus JJ, Tournay A. Novel mutation confirms seizure locus SCN1A is also familial hemiplegic migraine locus FHM3. <span><span class="ref-journal">Pediatr Neurol. </span>2007;<span class="ref-vol">37</span>:407–10.</span> [<a href="/pmc/articles/PMC2151385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2151385</span></a>] [<a href="/pubmed/18021921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18021921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.gaustadnes.1999.251">Gaustadnes M, Rudiger N, Moller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. <span><span class="ref-journal">Blood Coagul Fibrinolysis. </span>1999;<span class="ref-vol">10</span>:251–9.</span> [<a href="/pubmed/10456616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10456616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.hayashi.1998.166">Hayashi R, Tachikawa H, Watanabe R, Honda M, Katsumata Y. Familial hemiplegic migraine with irreversible brain damage. <span><span class="ref-journal">Intern Med. </span>1998;<span class="ref-vol">37</span>:166–8.</span> [<a href="/pubmed/9550598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9550598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.headache_classification_subcommittee_of_the_international_headache_society.2004.9">Headache Classification Subcommittee of the International Headache Society.  <em>The International Classification of Headache Disorders</em>. 2 ed. <span><span class="ref-journal">Cephalalgia. </span>2004;<span class="ref-vol">24</span>:9–160.</span> [<a href="/pubmed/14979299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14979299</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.heinzen.2012.1030">Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B, Tiziano FD, Fontaine B, Walley NM, Heavin S, Panagiotakaki E, Fiori S, Abiusi E, Di Pietro L, Sweney MT, Newcomb TM, Viollet L, Huff C, Jorde LB, Reyna SP, Murphy KJ, Shianna KV, Gumbs CE, Little L, Silver K, Pt&#x000e1;&#x0010d;ek LJ, Haan J, Ferrari MD, Bye AM, Herkes GK, Whitelaw CM, Webb D, Lynch BJ, Uldall P, King MD, Scheffer IE, Neri G, Arzimanoglou A, van den Maagdenberg AM, Sisodiya SM, Mikati MA, Goldstein DB, et al.  De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1030–4.</span> [<a href="/pmc/articles/PMC3442240/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3442240</span></a>] [<a href="/pubmed/22842232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22842232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.hutchinson.1995.817">Hutchinson M, O'Riordan J, Javed M, Quin E, Macerlaine D, Wilcox T, Parfrey N, Nagy TG, Tournier-Lasserve E. Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). <span><span class="ref-journal">Ann Neurol. </span>1995;<span class="ref-vol">38</span>:817–24.</span> [<a href="/pubmed/7486874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7486874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.jen.1999.274">Jen J. Calcium channelopathies in the central nervous system. <span><span class="ref-journal">Curr Opin Neurobiol. </span>1999;<span class="ref-vol">9</span>:274–80.</span> [<a href="/pubmed/10395579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10395579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.jodice.1997.1973">Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F, Ophoff RA, Frants RR, Frontali M. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:1973–8.</span> [<a href="/pubmed/9302278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9302278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.jurkatrott.2004.1857">Jurkat-Rott K, Freilinger T, Dreier JP, Herzog J, Gobel H, Petzold GC, Montagna P, Gasser T, Lehmann-Horn F, Dichgans M. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:1857–61.</span> [<a href="/pubmed/15159495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15159495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.kahlig.2008.9799">Kahlig KM, Rhodes TH, Pusch M, Freilinger T, Pereira-Monteiro JM, Ferrari MD, van den Maagdenberg AM, Dichgans M, George AL Jr. Divergent sodium channel defects in familial hemiplegic migraine. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2008;<span class="ref-vol">105</span>:9799–804.</span> [<a href="/pmc/articles/PMC2474506/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2474506</span></a>] [<a href="/pubmed/18621678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18621678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.kors.2003.684">Kors EE, Haan J, Giffin NJ, Pazdera L, Schnittger C, Lennox GG, Terwindt GM, Vermeulen FL, Van den Maagdenberg AM, Frants RR, Ferrari MD. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:684–8.</span> [<a href="/pubmed/12756131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12756131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.kors.2001.753">Kors EE, Terwindt GM, Vermeulen FL, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg AM, Haan J, Frants RR, Ferrari MD. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:753–60.</span> [<a href="/pubmed/11409427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11409427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.ophoff.1996.543">Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">87</span>:543–52.</span> [<a href="/pubmed/8898206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8898206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.riant.2005.281">Riant F, De Fusco M, Aridon P, Ducros A, Ploton C, Marchelli F, Maciazek J, Bousser MG, Casari G, Tournier-Lasserve E. ATP1A2 mutations in 11 families with familial hemiplegic migraine. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">26</span>:281.</span> [<a href="/pubmed/16088919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16088919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.riant.2010.967">Riant F, Ducros A, Ploton C, Barbance C, Depienne C, Tournier-Lasserve E. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:967–72.</span> [<a href="/pubmed/20837964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20837964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.riant.2008.817">Riant F, Mourtada R, Saugier-Veber P, Tournier-Lasserve E. Large CACNA1A deletion in a family with episodic ataxia type 2. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:817–20.</span> [<a href="/pubmed/18541804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18541804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.soragna.2003.161">Soragna D, Vettori A, Carraro G, Marchioni E, Vazza G, Bellini S, Tupler R, Savoldi F, Mostacciuolo ML. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:161–7.</span> [<a href="/pmc/articles/PMC378621/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378621</span></a>] [<a href="/pubmed/12474141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12474141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.spadaro.2004.177">Spadaro M, Ursu S, Lehmann-Horn F, Veneziano L, Antonini G, Giunti P, Frontali M, Jurkat-Rott K. A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. <span><span class="ref-journal">Neurogenetics. </span>2004;<span class="ref-vol">5</span>:177–85.</span> [<a href="/pubmed/15459825" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15459825</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.spranger.1999.150">Spranger M, Spranger S, Schwab S, Benninger C, Dichgans M. Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. <span><span class="ref-journal">Eur Neurol. </span>1999;<span class="ref-vol">41</span>:150–2.</span> [<a href="/pubmed/10202246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10202246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.swoboda.2004.884">Swoboda KJ, Kanavakis E, Xaidara A, Johnson JE, Leppert MF, Schlesinger-Massart MB, Ptacek LJ, Silver K, Youroukos S. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. <span><span class="ref-journal">Ann Neurol. </span>2004;<span class="ref-vol">55</span>:884–7.</span> [<a href="/pubmed/15174025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15174025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.tavraz.2008.31097">Tavraz NN, Friedrich T, D&#x000fc;rr KL, Koenderink JB, Bamberg E, Freilinger T, Dichgans M. Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2. <span><span class="ref-journal">J Biol Chem. </span>2008;<span class="ref-vol">283</span>:31097–106.</span> [<a href="/pmc/articles/PMC2662176/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2662176</span></a>] [<a href="/pubmed/18728015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18728015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.terwindt.2002.1016">Terwindt G, Kors E, Haan J, Vermeulen F, Van den Maagdenberg A, Frants R, Ferrari M. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. <span><span class="ref-journal">Arch Neurol. </span>2002;<span class="ref-vol">59</span>:1016–8.</span> [<a href="/pubmed/12056940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12056940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.terwindt.1998.1105">Terwindt GM, Ophoff RA, Haan J, Vergouwe MN, van Eijk R, Frants RR, Ferrari MD. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">50</span>:1105–10.</span> [<a href="/pubmed/9566402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9566402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.thomsen.2002.1379">Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. <span><span class="ref-journal">Brain. </span>2002;<span class="ref-vol">125</span>:1379–91.</span> [<a href="/pubmed/12023326" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12023326</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.thomsen.2007.346">Thomsen LL, Kirchmann M, Bjornsson A, Stefansson H, Jensen RM, Fasquel AC, Petursson H, Stefansson M, Frigge ML, Kong A, Gulcher J, Stefansson K, Olesen J. The genetic spectrum of a population-based sample of familial hemiplegic migraine. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:346–56.</span> [<a href="/pubmed/17142831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17142831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.thomsen.2008.914">Thomsen LL, Oestergaard E, Bjornsson A, Stefansson H, Fasquel AC, Gulcher J, Stefansson K, Olesen J. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. <span><span class="ref-journal">Cephalalgia. </span>2008;<span class="ref-vol">28</span>:914–21.</span> [<a href="/pubmed/18513263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18513263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.tottene.2009.762">Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, van den Maagdenberg AM, Ferrari MD, Pietrobon D. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. <span><span class="ref-journal">Neuron. </span>2009;<span class="ref-vol">61</span>:762–73.</span> [<a href="/pubmed/19285472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19285472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.tottene.2002.13284">Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, Pietrobon D. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2002;<span class="ref-vol">99</span>:13284–9.</span> [<a href="/pmc/articles/PMC130625/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC130625</span></a>] [<a href="/pubmed/12235360" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12235360</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.vahedi.2000.1040">Vahedi K, Denier C, Ducros A, Bousson PV, Levy C, Chabriat H, Haguenau PM, Tournier-Lasserve E, Bousser MG. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">55</span>:1040–2.</span> [<a href="/pubmed/11061267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11061267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.vahedi.2009.1178">Vahedi K, Depienne C, Le Fort D, Riant F, Chaine P, Trouillard O, Gaudric A, Morris MA, Leguern E, Tournier-Lasserve E, Bousser MG. Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:1178–83.</span> [<a href="/pubmed/19332696" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19332696</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.vanmolkot.2007.522">Vanmolkot KR, Babini E, de Vries B, Stam AH, Freilinger T, Terwindt GM, Norris L, Haan J, Frants RR, Ramadan NM, Ferrari MD, Pusch M, van den Maagdenberg AM, Dichgans M. The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:522.</span> [<a href="/pubmed/17397047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17397047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.vecchia.2015.8">Vecchia D, Tottene A, van den Maagdenberg AM, Pietrobon D. Abnormal cortical synaptic transmission in CaV2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans. <span><span class="ref-journal">Front Cell Neurosci. </span>2015;<span class="ref-vol">9</span>:8.</span> [<a href="/pmc/articles/PMC4330891/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4330891</span></a>] [<a href="/pubmed/25741235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25741235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.vecchia.2014.225">Vecchia D, Tottene A, van den Maagdenberg AM, Pietrobon D. Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in CaV2.1 knockin migraine mice. <span><span class="ref-journal">Neurobiol Dis. </span>2014;<span class="ref-vol">69</span>:225–34.</span> [<a href="/pmc/articles/PMC4107271/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4107271</span></a>] [<a href="/pubmed/24907493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24907493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.wessman.2002.652">Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hamalainen E, Broas P, Joslyn G, Hovatta I, Hiekkalinna T, Kaprio J, Ott J, Cantor RM, Zwart JA, Ilmavirta M, Havanka H, Farkkila M, Peltonen L, Palotie A. A susceptibility locus for migraine with aura, on chromosome 4q24. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:652–62.</span> [<a href="/pmc/articles/PMC384944/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384944</span></a>] [<a href="/pubmed/11836652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11836652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.wieser.2003.272">Wieser T, Mueller C, Evers S, Zierz S, Deufel T. Absence of known familial hemiplegic migraine (FHM) mutations in the CACNA1A gene in patients with common migraine: implications for genetic testing. <span><span class="ref-journal">Clin Chem Lab Med. </span>2003;<span class="ref-vol">41</span>:272–5.</span> [<a href="/pubmed/12705332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12705332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fhm.REF.zhuchenko.1997.62">Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">15</span>:62–9.</span> [<a href="/pubmed/8988170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8988170</span></a>]</div></li></ul></div></div><div id="fhm.Chapter_Notes"><h2 id="_fhm_Chapter_Notes_">Chapter Notes</h2><div id="fhm.Author_History"><h3>Author History</h3><p>Kathy Lou Gardner, MD; University of Pittsburgh (2001-2009)<br />Joanna C Jen, MD, PhD (2009-present)</p></div><div id="fhm.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 May 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 September 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 January 2007 (cd) Revision: mutations in <i>SCN1A</i> associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemiplegic migraine type 3</div></li><li class="half_rhythm"><div>14 December 2004 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>CACNA1A</i> clinically available</div></li><li class="half_rhythm"><div>15 March 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 December 2003 (cd) Revision: change in test availability</div></li><li class="half_rhythm"><div>3 October 2002 (kg) Author revisions</div></li><li class="half_rhythm"><div>16 September 2002 (kg) Author revisions</div></li><li class="half_rhythm"><div>17 July 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>October 2000 (kg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1388</span><span class="label">PMID: <a href="/pubmed/20301562" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301562</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fevr/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hyperchol/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1388&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1388/?report=reader">PubReader</a></li><li><a href="/books/NBK1388/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1388" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1388" style="display:none" title="Cite this Page"><div class="bk_tt">Jen JC. Familial Hemiplegic Migraine. 2001 Jul 17 [Updated 2015 May 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1388/pdf/Bookshelf_NBK1388.pdf">PDF version of this page</a> (482K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#fhm.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#fhm.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#fhm.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#fhm.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#fhm.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#fhm.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#fhm.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#fhm.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#fhm.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#fhm.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#fhm.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6323[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SCN1A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=477[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATP1A2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=773[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CACNA1A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1485330" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1485330" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1485330" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1485330" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30020674" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hemiplegic Migraine</a><span class="source">[StatPearls. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hemiplegic Migraine<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kumar A, Arora R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">StatPearls. 2019 Jan</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18405771" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Familial and sporadic hemiplegic migraine].</a><span class="source">[Rev Neurol (Paris). 2008]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Familial and sporadic hemiplegic migraine].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ducros A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Neurol (Paris). 2008 Mar; 164(3):216-24. Epub 2008 Mar 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12023326" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria.</a><span class="source">[Brain. 2002]</span><div class="brieflinkpop offscreen_noflow">A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain. 2002 Jun; 125(Pt 6):1379-91. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17142831" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The genetic spectrum of a population-based sample of familial hemiplegic migraine.</a><span class="source">[Brain. 2007]</span><div class="brieflinkpop offscreen_noflow">The genetic spectrum of a population-based sample of familial hemiplegic migraine.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thomsen LL, Kirchmann M, Bjornsson A, Stefansson H, Jensen RM, Fasquel AC, Petursson H, Stefansson M, Frigge ML, Kong A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain. 2007 Feb; 130(Pt 2):346-56. Epub 2006 Dec 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21533730" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The genetic features of 24 patients affected by familial and sporadic hemiplegic migraine.</a><span class="source">[Neurol Sci. 2011]</span><div class="brieflinkpop offscreen_noflow">The genetic features of 24 patients affected by familial and sporadic hemiplegic migraine.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gallanti A, Cardin V, Tonelli A, Bussone G, Bresolin N, Mariani C, Bassi MT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Sci. 2011 May; 32 Suppl 1:S141-2. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301562" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301562" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042a0775f66d18aaf394ce">Familial Hemiplegic Migraine - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Familial Hemiplegic Migraine - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:33:27-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE8836E5E041A06100000000075602BB&amp;ncbi_session=CE8836E5E042A071_1878SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1388%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1388&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1388/&amp;ncbi_pagename=Familial Hemiplegic Migraine - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8836E5E042A071_1878SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>